Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Dividends Paid - Preferred (2023 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Dividends Paid - Preferred over the past 2 years, most recently at $822000.0 for Q4 2024.

For Q4 2024, Dividends Paid - Preferred rose 7.73% year-over-year to $822000.0; the TTM value through Nov 2024 reached $3.2 million, up 19.48%, while the annual FY2024 figure was $3.1 million, 164.66% up from the prior year.
Dividends Paid - Preferred for Q4 2024 was $822000.0 at Lifecore Biomedical, Inc. \De\, up from $806000.0 in the prior quarter.
Over five years, Dividends Paid - Preferred peaked at $822000.0 in Q4 2024 and troughed at $428000.0 in Q1 2023.